Skip to main content

Table 2 Panellists experience with clients with CIPN

From: Development of the consensus-based recommendations for Podiatry care of Neuropathy In Cancer Survivors (PodNICS): a Delphi consensus study of Australian podiatrists

Category

Total number

Percentage

Seen clients with CIPN in the last year (n = 21)

15 Yes

71%

5 No

24%

1 No response

5%

Estimated average number of clients with CIPN seen in the last 3 months (n = 15)

10 (0–5 clients with CIPN)

67%

2 (5–10 clients with CIPN)

13%

2 (10–15 clients with CIPN)

13%

1 (15–20 clients with CIPN)

8%

Referral sources for clients with CIPN (n = 17)

11 General Practitioner

65%

6 Self-referred

35%

5 Oncologist

29%

5 Allied health or exercise professionals e.g., Physiotherapist, Exercise Physiologist, Speech pathologist etc

29%

3 Nurse Practitioners

18%

1 My Aged Care

6%

1 Hospital Outpatients

6%

1 Neurologist

6%

Common funding sources to attend Podiatry services for people with CIPN (n = 20)

12 Publicly funded (e.g., attending a hospital or community-based practice)

60%

5 Chronic disease management plan

25%

CDMP/Medicare

10%

2 Private health

5%

1 Commonwealth home support program and home care package

 

Reason for management choices (n = 17)

8 Clinical experience and previous success to management options

47%

4 Learning from senior/ experienced podiatry colleagues

23%

4 Knowledge crossover from managing Diabetes related foot concerns

23%

2 Learning from other professionals including neurologists, diabetes specialists, oncology nurses and pain specialists

12%

2 Patient feedback

12%

2 Current evidence

12%

2 Anecdote and learnt skills (unknown source)

12%

1 Learnt skills from entry-level podiatrists who retain knowledge of modern interventions learnt fresh from university

6%